X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.prnewswire.com/news-releases/acurx-pharmaceuticals-announces-presentation-of-ibezapolostat-phase-2-clinical-trial-results-at-upcoming-escmid-2024-scientific-conference-302127648.html
https://www.prnewswire.com/news-releases/acurx-pharmaceuticals-inc-to-discuss-first-quarter-2024-financial-results-on-may-15-2024-conference-call-and-provide-business-update-302124790.html
https://www.prnewswire.com/news-releases/acurx-pharmaceuticals-inc-to-discuss-fourth-quarter-and-full-year-2023-financial-results-on-march-18-2024-conference-call-and-provide-business-update-302077838.html
https://www.prnewswire.com/news-releases/acurx-announces-fda-has-granted-an-end-of-phase-2-meeting-for-ibezapolstat-for-c-difficile-infection-and-the-european-medicines-agency-granted-sme-designation-for-ibezapolstat-eu-development-302072034.html
https://www.prnewswire.com/news-releases/acurx-announces-positive-extended-clinical-cure-data-for-ibezapolstat-from-phase-2b-clinical-trial-in-cdi-patients-302046101.html
https://www.prnewswire.com/news-releases/acurx-pharmaceuticals-to-present-at-the-microcap-conference-january-31-2024---february-1-2024-302041587.html
https://www.prnewswire.com/news-releases/acurx-announces-positive-comparative-microbiology-and-microbiome-data-for-ibezapolstat-from-phase-2b-clinical-trial-in-cdi-patients-302036789.html
https://www.prnewswire.com/news-releases/acurx-to-present-at-the-42nd-annual-jp-morgan-healthcare-conference-302024975.html
https://www.prnewswire.com/news-releases/acurx-announces-positive-phase-2b-results-showing-100-of-patients-who-had-clinical-cure-with-ibezapolstat-also-had-sustained-clinical-cure-302010978.html
https://www.prnewswire.com/news-releases/acurx-pharmaceuticals-inc-reports-third-quarter-2023-results-and-provides-business-update-301985362.html
Market Place
Share 
